Geoffrey Wells, PhD

1998 Cancer Research Laboratories, School of Pharmaceutical Sciences University of Nottingham, Nottingham, England, United Kingdom 
 1998-2002 The School of Pharmacy University of London, London, England, United Kingdom 
 2002-2004 Pharminox Ltd 
 2007- School of Pharmacy University College London, London, United Kingdom 
"Geoffrey Wells"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Breen AF, Wells G, Turyanska L, et al. (2019) Development of novel apoferritin formulations for antitumour benzothiazoles. Cancer Reports (Hoboken, N.J.). 2: e1155
Breen AF, Scurr D, Cassioli ML, et al. (2019) Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery. International Journal of Nanomedicine. 14: 9525-9534
Shih PC, Yang Y, Parkinson GN, et al. (2018) A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3). Oncotarget. 9: 32690-32701
König J, Wyllie S, Wells G, et al. (2011) Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism. The Journal of Biological Chemistry. 286: 8523-33
McCarroll AJ, Matthews CS, Wells G, et al. (2010) Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions. Organic & Biomolecular Chemistry. 8: 2078-84
Aiello S, Wells G, Stone EL, et al. (2008) Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648). Journal of Medicinal Chemistry. 51: 5135-9
Lion CJ, Matthews CS, Wells G, et al. (2006) Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones ('quinols'). Bioorganic & Medicinal Chemistry Letters. 16: 5005-8
Mortimer CG, Wells G, Crochard JP, et al. (2006) Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. Journal of Medicinal Chemistry. 49: 179-85
Bradshaw TD, Matthews CS, Cookson J, et al. (2005) Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Research. 65: 3911-9
Berry JM, Bradshaw TD, Fichtner I, et al. (2005) Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents. Journal of Medicinal Chemistry. 48: 639-44
See more...